Cost-effectiveness of roflumilast as an add-on treatment to long-acting bronchodilators in the treatment of COPD associated with chronic bronchitis in the United Kingdom

Cost-effectiveness of roflumilast as an add-on treatment to long-acting bronchodilators in the treatment of COPD associated with chronic bronchitis in the United Kingdom

Bibliographic Details
Main Authors:	Samyshkin, Yevgeniy, Kotchie, Robert W., Mörk, Ann-Christin, Briggs, Andrew H., Bateman, Eric D.
Format:	Online
Language:	English
Published:	Springer Berlin Heidelberg 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889819/

Similar Items

Cost-effectiveness of roflumilast in combination with bronchodilator therapies in patients with severe and very severe COPD in Switzerland
by: Samyshkin, Yevgeniy, et al.
Published: (2013)

Cost-effectiveness of available treatment options for patients suffering from severe COPD in the UK: a fully incremental analysis
by: Hertel, Nadine, et al.
Published: (2012)

Roflumilast: a review of its use in the treatment of COPD
by: Wedzicha, Jadwiga A, et al.
Published: (2016)

Cost-effectiveness of roflumilast as an add-on to triple inhaled therapy versus triple inhaled therapy in patients with severe and very severe COPD associated with chronic bronchitis in the UK
by: Kiff C, et al.
Published: (2018-09-01)

Roflumilast in COPD: a Brazilian perspective
by: Stirbulov, Roberto, et al.
Published: (2015)

The role of bronchodilator treatment in the prevention of exacerbations of COPD
by: Wedzicha, Jadwiga A., et al.
Published: (2012)

Bronchodilators use in patients with COPD
by: Dong, Yaa-Hui, et al.
Published: (2015)

COPD: maximization of bronchodilation
by: Nardini, Stefano, et al.
Published: (2014)

New therapeutic options in the management of COPD – focus on roflumilast
by: Antoniu, Sabina Antonela
Published: (2011)

Does roflumilast induce phagocytic activity in COPD patients?
by: Ghosh, Baishakhi, et al.
Published: (2015)

Vulnerable COPD patients with comorbidities: the role of roflumilast
by: Lipari, Melissa, et al.
Published: (2014)

Efficacy and Safety of Roflumilast in Korean Patients with COPD
by: Lee, Jae Seung, et al.
Published: (2016)

Comparative efficacy of long-acting bronchodilators for COPD - a network meta-analysis
by: Cope, Shannon, et al.
Published: (2013)

Differential pharmacology and clinical utility of long-acting bronchodilators in COPD – focus on olodaterol
by: Matera, Maria Gabriella, et al.
Published: (2015)

Short Term Effects of Tiotropium on COPD Patients Treated with Long Acting Bronchodilators
by: Nicolini, Antonello
Published: (2012)

Optimizing bronchodilation in the prevention of COPD exacerbations
by: Marc Miravitlles, et al.
Published: (2017-06-01)

Severe COPD Exacerbation Risk and Long-Acting Bronchodilator Treatments: Comparison of Three Observational Data Analysis Methods
by: Roberts, Melissa H., et al.
Published: (2015)

Potential treatment benefits and safety of roflumilast in COPD: a systematic review and meta-analysis
by: Yuan, Lianfang, et al.
Published: (2016)

Chronic Bronchitis and Its Treatment
Published: (1890)

Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study
by: Bateman, Eric D., et al.
Published: (2013)

Add-on treatment with nebulized hypertonic saline in a child with plastic bronchitis after the Glenn procedure*, **
by: Lis, Grzegorz, et al.
Published: (2014)

Effect of theophylline on exercise capacity in COPD patients treated with combination long-acting bronchodilator therapy: a pilot study
by: Voduc, Nha, et al.
Published: (2012)

A new user cohort study comparing the safety of long-acting inhaled bronchodilators in COPD
by: Jara, Michele, et al.
Published: (2012)

Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study
by: Kozma, Chris M, et al.
Published: (2011)

Long-acting bronchodilator use after hospitalization for COPD: an observational study of health insurance claims data
by: Baker, Christine L, et al.
Published: (2014)

Correction to: Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis
by: Fabiano Di Marco, et al.
Published: (2018-04-01)

Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis
by: Fabiano Di Marco, et al.
Published: (2018-01-01)

Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy
by: Halpin, David M. G., et al.
Published: (2016)

Characteristics, disease burden and costs of COPD patients in the two years following initiation of long-acting bronchodilators in UK primary care
by: Punekar, Yogesh Suresh, et al.
Published: (2015)

Characteristics of patients with COPD newly prescribed a long-acting bronchodilator: a retrospective cohort study
by: Wurst, Keele E, et al.
Published: (2014)

The Forms, Complications, Causes, and Treatment of Bronchitis
Published: (1867)

Roflumilast: the evidence for its clinical potential in the treatment of chronic obstructive pulmonary disease
by: Wagner, Linda Timm, et al.
Published: (2005)

New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension delivery technology
by: D'Urzo AD, et al.
Published: (2018-09-01)

Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations
by: Calverley, Peter M, et al.
Published: (2016)

Bronchodilator reversibility in patients with COPD revisited: short-term reproducibility
by: Pascoe, Steven, et al.
Published: (2016)

Bronchodilator response of advanced lung function parameters depending on COPD severity
by: Jarenbäck, Linnea, et al.
Published: (2016)

Comparative efficacy of combination bronchodilator therapies in COPD: a network meta-analysis
by: Huisman, Eline L, et al.
Published: (2015)

A real-world evaluation of indacaterol and other bronchodilators in COPD: the INFLOW study
by: Juvelekian, Georges, et al.
Published: (2015)

Airway wall thickness is increased in COPD patients with bronchodilator responsiveness
by: Kim, Victor, et al.
Published: (2014)

Can bronchodilators improve exercise tolerance in COPD patients without dynamic hyperinflation? *
by: Scuarcialupi, Maria Enedina Aquino, et al.
Published: (2014)